Johnson & Johnson said it would sell its ortho clinical diagnostics division to the Carlyle Group LP for $4.15 billion, shedding a slow-growing business to focus on more lucrative products. The unit includes laboratory diagnostics products and blood-transfusion-screening equipment, and it has operations in 130 countries. The acquisition is expected to be finalized in mid-2014. Read the full story